Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Planned sale Director sold 17,800 shares at $7.09 ($126,202)
  2. 4 Planned sale SVP, Products Business sold 3,000 shares at $6.53 ($19,590)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Planned sale SVP, Products Business sold 3,000 shares at $8.40 ($25,200)
  5. 4 Shares withheld for taxes SVP, Products Business gave up 694 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 3,964 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 2,018 shares (to pay taxes)
  8. 4 Shares withheld for taxes SVP, Bioservices gave up 1,741 shares (to pay taxes)
  9. 4 Planned sale Director sold 13,761 shares at an average $8.40 ($115,610)
  10. 4 Planned sale Director sold 15,481 shares at an average $8.40 ($129,994)
  11. 4 Planned sale Director sold 15,481 shares at $8.28 ($128,183)
  12. 4 Grant or award Director acquired 25,344 shares (grant or award)
  13. 4 Grant or award Director acquired 25,344 shares (grant or award)
  14. 4 Grant or award Director acquired 25,344 shares (grant or award)
  15. 4 Planned sale Director sold 17,202 shares at an average $8.40 ($144,453)
  16. 4 Grant or award Director acquired 25,344 shares (grant or award)
  17. 4 Grant or award Chairman acquired 25,344 shares (grant or award)
  18. 4 Grant or award SVP, Products Business acquired 100,111 shares (grant or award)
  19. 4 Grant or award SVP, R&D, CMO acquired 100,111 shares (grant or award)
  20. 4 Grant or award EVP, Quality & Ethics, and CPL acquired 100,111 shares (grant or award)

Page 1 of 49 · 970 filings